Barden Capital Management Inc. raised its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 18.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,206 shares of the company’s stock after acquiring an additional 509 shares during […]